1/39
Looks like no tags are added yet.
approach toward genetic testing
depends on if single person or population is carrying the problem, depends on if gene is known or unknown
single person
always start w/ pedigree analysis (2 gen above and below)
population
can't draw a pedigree, use population testing/screening technique instead
known gene
mutational analysis: must do pretest counseling FIRST; warn about things like potential to find out about infertility, new diseases etc. -> depending on results of pretest counseling then you can decide on mutational analysis
unknown gene
linkage analysis (starting test): done when you have multigenerational info or multiple ppl in family w/ unknown gene disorder, tells about general area of where disease is occurring on chromosome, tells you area you should focus one -> then you can apply other tests
indications for cytogenic analysis
developmental delay/intellectual disability (esp. w/ anomoalies), ambiguous internal/external genitalia, girls w/ primary amenorrhea (don't get period) and boys w/ delayed puberty, males w/ learning/behavioral disorders who are taller than expected, specific malignant and premalignant diseases, family history of similarly affected children, couples w/ multiple spontaneous abortions of unknown cause, prenatal diagnosis
prenatal diagnosis indication for cytogenetic analysis
advanced maternal age, carrier present, prior affected child, abnormal serum or cell-free DNA screening (non-invasive screening, in maternal blood, tests for chromosomes of baby, tells you gender), fetal anomaly or growth restriction on US (scans to predict appearance of disease after birth and see if you can fix it before birth)
challenges in dx of genetic disease
complex/multifactorial diseases (no obviously predominant disease locus)
monogenic
influenced predominantly by single gene locus
oligogenic
disease phenotype may be dependent on a few genes
polygenic
multiple genetic factors determine phenotype, each making a small contribution, eg. T1 and T2 DM, CAD, stroke, RA, alzheimers
genetic risk factors
don't cause disease, just increase risk
whole genome sequencing
process that determines the DNA sequence of an entire genome, HGP
next generation sequencing (NGS)
takes <24 hrs (quicker), <$1k, getting cheaper still, sequencing by synthesis, resequencing, 99.9% accurate (lots of data given), replaces some older techniques, only makes sense if looking at MULTIPLE genes (15-20), NOT used for single gene mutations, can identify single nucleotide changes, can't identify balanced translocation, preferred over karyotyping
sequencing by synthesis (NGS)
break genomic DNA and add linkers (short stretch of oligonucleotides of known sequence) -> amplify the linkers, put on a chip, then read them -> fluorescent signal (G attached to green, T attached to blue) -> captured by computer and computer organizes/aligns it, millions of rxns
resequencing (NGS)
compare w/ sequence genome, find abnormalities thru comparison
karyotyping
examines chromosomes in sample of cells usually in metaphase or prometaphase when the chromosomes are most condensed, giemsa stain, slow and labor intensive (1-2 weeks), preimplantation genetic testing - IVF, gradually being replaced by NGS, can't identify anything under 5 million bp, easily done anywhere, low resolution of chromosome
karyotyping process
chromosome dense (metaphase/prometaphase) -> apply anti-tubulin drug (colchicine) -> arrests chromosomes by stopping spindle fiber function -> chromosome visible -> stain them (giemsa stain) -> bind in areas w/ A and T, gives banding pattern, can identify translocations, etc.
FISH
fluorescence in situ hybridization
chromosome FISH
less expensive and fast (1-2 days), KNOWN mutation is required (premade probe according to defect), up to 100k bp, less expensive than NGS but varies on how expensive it is vs karyotyping, open up chromosome and apply signal
chromosome FISH process
fix chromosome preparations on microscopic slides, treat slides to denature DNA and hybridize fluorescently labeled probes of interest to denatured DNA, locations of fluorescent signals are recorded against a background stain that binds to all DNA sequences
gene linkage
alleles at closely neighboring loci w/ recomb frequency of
linkage analysis
only tells location on chromosome of mutation -> once identified use NGS to analyze area, req. multiple people to have disease, checks for linked genes with recomb frequency <50%, LOD score
LOD score
statistical estimate of whether 2 loci are likely to lie near each other on a chromosome and are therefore likely to be inherited tog, score of 3 or more indicates they are linked and close to one another
linkage analysis example
SNP B = ppl w/out disease, SNP A = ppl w/ disease (pattern), disease-causing mutation should be somewhere near SNP A -> NGS around this area to find the mutation more closely
exome
collective term for all exons in genome, majority of disease causing mutations occur in exons of protein-coding genes
exome sequencing
cost effective, less laborious, sequencing fraction (just over 1% of genome), is easier and cheaper than genome sequencing, ONLY sequences exomes (exons = <2% of coding genome), 95% of genetic disorders occur in protein coding region, start in pt w/ genetic disorder w/out diagnosis and doesn't know gene and NGS, can find RARER diseases for a single person
exome sequencing process
involves first capturing exons from DNA of affected individuals -> then sequencing the captured DNA
thrifty phenotype
adaptation that maximizes change of surviving in an adverse environment w/ limited calorie intake, fetal nutrient starvation -> thrifty phenotype -> low metabolic rate and reduced pancreatic B cell mass and islet function
low birth rate risks
lead to increased risk of HTN, CVD, stroke, T2DM
thrifty phenotype hypothesis
low birth weight babies/babies in restricted womb environment; after birth can't handle normal amounts of nutrients bcos it got used to having limited amt of nutrients (similar to spice tolerance), decreased metabolic rate -> baby gets used -> normal nutrients feel excessive to baby -> increased risk of disease
CVD, diabetes (can't handle sugar), obesity
phenocopy
similar phenotype arising from a different cause -> often environmental or nongenetic -> can often mimic genetic disorder, makes diagnosis challenging
phenocopy example
alzheimers disease diagnosis vs other dementia disorders (lewy dementia, frontotemporal dementia, etc.), can only diagnose after death and biopsy brain
genome-wide association study (GWAS)
helps identify susceptibility locus in complex diseases, looks into genetic factors of complex disease, useful in finding genetic variations of common, complex diseases like asthma, cance, diabetes, heart disease, mental illness
GWAS process
rapidly scanning markers (SNPs) across complete sets of DNA or genomes of many people to find genetic variations associated w/ a particular disease, compare SNPs from all these ppl w/ and w/OUT disease to figure out which variant is likely pathogenic, new genetic associations -> better strategies to detect, treat, and prevent disease
GWAS in IBD
new insights into biological pathways -> new approaches in treating disease, successful in Crohn's disease and ulcerative colitis (both results from abnormal immune responses to gut microbiota), identified 320 IBD risk loci (2023); most are shared by both diseases, revealed role of autophagy in Crohn's disease, IL23R locus pointed to IL-23 blockers (ustekinumab) -> now approved for IBD
environmental basis of complex disease
case-control studies, prospective cohort studies
case-control studies
most widely used method of investigating genetic and environmental basis of complex disease, HOWEVER cases and controls are investigated retrospectively -> BIAS (eg. bias of selection of subjects to be studied), identifies ppl w/ and w/out disease and what they were exposed to, easier and cheaper but prone to bias
prospective cohort studies
NO BIAS, takes a long time (months-years), ppl can fall out of study over time or come in, effective at finding environmental causes/how disease develops